Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.

PURPOSE: Radical radiotherapy for prostate cancer is effective but dose limited because of the proximity of normal tissues. Comprehensive dose-volume analysis of the incidence of clinically relevant late rectal toxicities could indicate how the dose to the rectum should be constrained. Previous emph...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Gulliford, S, Foo, K, Morgan, R, Aird, E, Bidmead, A, Critchley, H, Evans, P, Gianolini, S, Mayles, W, Moore, A, Sánchez-Nieto, B, Partridge, M, Sydes, MR, Webb, S, Dearnaley, D
Materialtyp:	Journal article
Språk:	English
Publicerad:	2010

Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.

Liknande verk